Shilpa Medicare credit ratios

Per cent unless marked ×
Tap a line for its trendLast 12Mto Jun 2026FY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
658658586936796
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
613613558905774
0.25×0.25×0.25×0.52×0.45×
0.24×0.24×0.24×0.50×0.44×
1.51×1.51×1.85×3.83×7.78×
1.28×1.41×1.76×3.70×7.57×
5.36×5.36×2.70×1.49×0.12×
20.3%20.3%19.9%34.2%31.0%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

SHILPAMED₹935.60

Shilpa Medicare Ltd.

· Pharma & Health
₹ CrorePeersNATCOPHARMSPARCSTARRUBICONSUPRIYATHYROCAREVIYASHPARKHOSPSMcap ₹18,300 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Total Debt795.7935.6586.4658.0658.0
Net Debt774.2905.2557.8612.8612.8
Total Debt/Equity0.450.520.250.250.25
Net Debt/Equity0.440.500.240.240.24
Total Debt/EBITDA7.783.831.851.511.51
Net Debt/EBITDA7.573.701.761.411.28
Interest Coverage (EBIT/Interest)0.121.492.705.365.36
Total Debt/Total Capital %30.9634.2019.8820.2520.25
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.